BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.
Professor Shiyue Fang from the Department of Chemistry, Michigan Technological University, accepted BOC Sciences' invitation to present his insightful ideas about sensitive nucleic acid applications and chemical synthesis.
BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.
The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.
BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products.
BOC Sciences grandly announced the schedule of a free webinar on September 19th, 2022, at 11:00 EDT, which is a laudable event centering on the hot spot of RNA research during the pandemic.
BOC Sciences developed strain expression systems for fermentation to help researchers greatly enhance fermentation productivity while significantly reducing costs.
"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public.
BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate technology transfer of medicines from research to commercial scale.
The BIO International Convention just ended on June 16th at San Diego Convention Center. BOC Sciences exhibited a whole set of preclinical CRO & fermentation CDMO services and attracted many interested visitors stopping by to have an informative in-person meeting.
As the two industry-renowned exhibitions—CPhI North America and TIDES USA 2022 draw near, BOC Sciences is making final efforts to let the news reach as many researchers as possible, especially those who are struggling to find the best mRNA services.
BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022.
Lately, BOC Sciences projects a webinar themed as Targeting RNA Structure as a Therapeutic Strategy, awaiting broad participation on January 19th, 2022.
As a professional medicinal chemistry expert as well as a leading practitioner, BOC Sciences recently rearranges its relevant business, aiming to provide excellent analysis and purification service for scientists who are carrying out drug discovery projects.
BOC Sciences recently announces to enhance its one-stop compound screening platform, which is efficient, economical and systematic, aiming to help scientists fulfill their screening needs arising from drug R&D projects.
BOC Sciences announces to upgrade its already well-established bioconjugation service by extending the business range to biomolecule labeling, antibody conjugation, as well as other conjugation services.
BOC Sciences announces to continuously improve its Superparamagnetic Iron Oxide Nano/Micro Particles Preparation service for researchers who are engaged with chemotherapy study.
BOC Sciences, one of the major chemical providers, announced to newly introduce dozens of IDO inhibitors in order to facilitate facilitating researchers’ efforts in drug discovery and drug design both academically and industrially.
Satisfied Users & 
Approved Press Releases
